These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22842952)

  • 21. Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.
    Kanis JA; McCloskey EV; Johansson H; Strom O; Borgstrom F; Oden A;
    Osteoporos Int; 2008 Oct; 19(10):1395-408. PubMed ID: 18751937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of proposals of Belgian Social Security Institute for reimbursement of bone densitometry tests. Toward a cost-effective strategy for osteoporosis screening?
    Ben Sedrine W; Ethgen O; Devogelaer JP; Depresseux G; Kaufman JM; Goemaere S; Reginster JY
    Aging Clin Exp Res; 2004 Oct; 16(5):413-9. PubMed ID: 15636469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective risk of osteoporotic fractures in patients with advanced chronic obstructive pulmonary disease.
    Gupta A; Greening NJ; Evans RA; Samuels A; Toms N; Steiner MC
    Chron Respir Dis; 2019; 16():1479972318769763. PubMed ID: 29661041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of abaloparatide on vertebral, nonvertebral, major osteoporotic, and clinical fractures in a subset of postmenopausal women at increased risk of fracture by FRAX probability.
    McCloskey EV; Fitzpatrick LA; Hu MY; Williams G; Kanis JA
    Arch Osteoporos; 2019 Feb; 14(1):15. PubMed ID: 30719589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk-equivalent T-score adjustment for using lumbar spine trabecular bone score (TBS): the Manitoba BMD registry.
    Leslie WD; Shevroja E; Johansson H; McCloskey EV; Harvey NC; Kanis JA; Hans D
    Osteoporos Int; 2018 Mar; 29(3):751-758. PubMed ID: 29392355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ten-year absolute fracture risk and hip bone strength in Canadian women with systemic lupus erythematosus.
    Lee JJ; Aghdassi E; Cheung AM; Morrison S; Cymet A; Peeva V; Neville C; Hewitt S; DaCosta D; Pineau C; Pope J; Fortin PR
    J Rheumatol; 2012 Jul; 39(7):1378-84. PubMed ID: 22660811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment.
    Leslie WD; Lix LM; Langsetmo L; Berger C; Goltzman D; Hanley DA; Adachi JD; Johansson H; Oden A; McCloskey E; Kanis JA
    Osteoporos Int; 2011 Mar; 22(3):817-27. PubMed ID: 21161509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An investigation of the bidirectional link between osteoporosis and periodontitis.
    Penoni DC; Vettore MV; Torres SR; Farias MLF; Leão ATT
    Arch Osteoporos; 2019 Aug; 14(1):94. PubMed ID: 31444638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osteoporosis in spine surgery patients: what is the best way to diagnose osteoporosis in this population?
    St Jeor JD; Jackson TJ; Xiong AE; Kadri A; Freedman BA; Sebastian AS; Currier BL; Nassr A; Fogelson JL; Kennel KA; Anderson PA; Elder BD
    Neurosurg Focus; 2020 Aug; 49(2):E4. PubMed ID: 32738802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How well do the FRAX (Australia) and Garvan calculators predict incident fractures? Data from the Geelong Osteoporosis Study.
    Holloway-Kew KL; Zhang Y; Betson AG; Anderson KB; Hans D; Hyde NK; Nicholson GC; Pocock NA; Kotowicz MA; Pasco JA
    Osteoporos Int; 2019 Oct; 30(10):2129-2139. PubMed ID: 31317250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spine-hip T-score difference predicts major osteoporotic fracture risk independent of FRAX(®): a population-based report from CAMOS.
    Leslie WD; Kovacs CS; Olszynski WP; Towheed T; Kaiser SM; Prior JC; Josse RG; Jamal SA; Kreiger N; Goltzman D;
    J Clin Densitom; 2011; 14(3):286-93. PubMed ID: 21723768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effective osteoporosis treatment thresholds for people living with HIV infection in Greece.
    Makras P; Boubouchairopoulou N; Katsarolis I; Athanasakis K
    J Musculoskelet Neuronal Interact; 2017 Dec; 17(4):292-298. PubMed ID: 29199188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spine bone texture assessed by trabecular bone score (TBS) predicts osteoporotic fractures in men: the Manitoba Bone Density Program.
    Leslie WD; Aubry-Rozier B; Lix LM; Morin SN; Majumdar SR; Hans D
    Bone; 2014 Oct; 67():10-4. PubMed ID: 24998455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effective osteoporosis treatment thresholds in Greece.
    Makras P; Athanasakis K; Boubouchairopoulou N; Rizou S; Anastasilakis AD; Kyriopoulos J; Lyritis GP
    Osteoporos Int; 2015 Jul; 26(7):1949-57. PubMed ID: 25740208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the 10-year risk of fracture in Italian postmenopausal women using FRAX®: a north Italian multicenter study.
    Pedrazzoni M; Girasole G; Giusti A; Barone A; Pioli G; Passeri G; Palummeri E; Bianchi G
    J Endocrinol Invest; 2011 Dec; 34(11):e386-91. PubMed ID: 21750394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of the World Health Organization Fracture Risk Assessment Tool to predict need for dual-energy X-ray absorptiometry scanning in postmenopausal women.
    Chao AS; Chen FP; Lin YC; Huang TS; Fan CM; Yu YW
    Taiwan J Obstet Gynecol; 2015 Dec; 54(6):722-5. PubMed ID: 26700992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of the new National Bone Health Alliance (NBHA) diagnostic criteria on the prevalence of osteoporosis in the USA.
    Wright NC; Saag KG; Dawson-Hughes B; Khosla S; Siris ES
    Osteoporos Int; 2017 Apr; 28(4):1225-1232. PubMed ID: 27966104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Denosumab: a cost-effective alternative for older men with osteoporosis from a Swedish payer perspective.
    Parthan A; Kruse M; Agodoa I; Silverman S; Orwoll E
    Bone; 2014 Feb; 59():105-13. PubMed ID: 24231131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
    Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
    Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
    Leslie WD; Majumdar SR; Morin SN; Lix LM; Schousboe JT; Ensrud KE; Johansson H; McCloskey EV; Kanis JA
    Osteoporos Int; 2018 Mar; 29(3):759-767. PubMed ID: 29404625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.